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Organization and Nucleotide Sequences of Two Lactococcal
Bacteriocin Operons
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Two distinct regions of the Lactococcus lactis subsp. cremoris 9B4 plasmid p9B4-6, each of which specified
bacteriocin production as well as immunity, have been sequenced and analyzed by deletion and frameshift
mutation analyses. On a 1.8-kb ScaI-ClaI fragment specifying low antagonistic activity, three open reading
frames (ORFs) were present, which were organized in an operon. The first two ORFs, containing 69 and 77
codons, respectively, were involved in bacteriocin activity, whereas the third ORF, containing 154 codons, was
essential for immunity. Primer extension analysis indicated the presence of a promoter upstream of the ORFs.
Two ORFs were present on a 1.3-kb ScaI-HindIII fragment specifying high antagonistic activity. The first
ORF, containing 75 codons, specified bacteriocin activity. The second ORF, containing 98 codons, specified
immunity. The nucleotide sequences of both fragments upstream of the first ORFs as well as the first 20 bp of
the first ORF of both bacteriocin operons appeared to be identical.
The ability of various bacteria to inhibit the growth of
other bacteria is well documented (9, 19). In many cases it
was demonstrated that the antagonistic activity was attrib-
utable to molecules of a proteinaceous nature, termed bac-
teriocins. The first bacteriocins to be discovered were the
colicins produced by Escherichia coli, and extensive knowl-
edge is now available concerning their genetics (8). In
general, three genes are required for colicin production: a
gene encoding the functional colicin, an immunity gene, and
a gene essential for the release of the colicin. For most of the
colicins investigated, the various genes are transcribed from
a common promoter, but in some cases the colicin immunity
gene is under control of a different promoter.
In contrast to bacteriocins produced by gram-negative
bacteria, less is known about bacteriocins and their genetic
determinants of gram-positive bacteria. In recent years
special attention has been paid to bacteriocin production by
lactic acid bacteria used in food fermentation and preserva-
tion. Several of these bacteriocins have been investigated
with respect to their genetic determinants and biochemical
characteristics (10). The gene encoding the precursor of the
protein antibiotic nisin of Lactococcus lactis subsp. lactis
ATCC 11454 has been cloned and sequenced (3). For several
species of lactic acid bacteria the genetic determinants of
bacteriocin activity were shown to be plasmid located (6, 7,
15, 17). One of the plasmids, which has been identified by
Neve et al. (15) to encode bacteriocin production, was a
60-kb conjugative plasmid (p9B4-6) from L. lactis subsp.
cremoris 9B4. Recently, we have cloned two fragments of
p9B4-6 which were responsible for bacteriocin production
and immunity. One was a 1.8-kb ScaI-ClaI fragment with
low antagonistic activity (pMB225), and the other was a
1.3-kb ScaI-HindIII fragment specifying high antagonistic
activity (pMB553) (21). Inhibition experiments showed that
the two bacteriocins had different specificities.
We report on the sequence analysis of the two bacteriocin
regions and show that the open reading frames (ORFs) found
on these fragments are involved in bacteriocin production
and immunity and are transcribed as an operon.
* Corresponding author.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial
strains and plasmids used are listed in Table 1. The growth
media for E. coli and L. lactis and the selective conditions
for maintaining the various plasmids have been described
previously (21).
Molecular cloning. Plasmid DNA was isolated from E. coli
as described by Birnboim and Doly (2). With some modifi-
cations (22), the same method was used for the isolation of
plasmids from L. lactis. Restriction enzymes, the Klenow
fragment of the E. coli DNA polymerase I, RNasin RNase
inhibitor, avian myeoblastosis virus reverse transcriptase,
and T4 DNA ligase were purchased from Boehringer, Mann-
heim, Federal Republic of Germany, and were used as
recommended by the supplier. AsuIl was obtained from
Promega Biotec, Madison, Wis., and NlaIII was from New
England BioLabs, Beverly, Mass. DNA cloning and manip-
ulation techniques were performed essentially as described
by Maniatis et al. (14). E. coli cells were made competent
and were transformed by the method of Mandel and Higa
(13). Transformation of L. lactis was done by electropora-
tion with a Bio-Rad gene pulser (Bio-Rad Laboratories,
Richmond, Calif.) by the method of Van der Lelie et al. (23).
Bacteriocin assay. The method used for screening L. lactis
transformants for bacteriocin activity has been described
previously (21). L. lactis IL1403 was used as the indicator
strain.
DNA sequencing. Nucleotide sequences were determined
by sequencing double-stranded DNA in two orientations by
the dideoxy-chain method of Sanger et al. (16), using the T7
sequencing kit (Pharmacia, Uppsala, Sweden). Synthetic
oligodeoxyribonucleotides were synthesized with an Ap-
plied Biosystems 391 PCR-Mate (Applied Biosystems, Fos-
ter City, Calif.).
Primer extension. RNA was isolated from L. lactis by the
method described by Van der Vossen et al. (24). Synthetic
primer (1 ,ug) was hybridized to 10 ,ug of RNA in a total
volume of 40 ,ul containing 50 mM Tris hydrochloride (pH
8.3), 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, and 30
U of RNasin. This mixture was heated for 3 min at 65°C and
was subsequently allowed to cool to room temperature. The
volume was increased to 50 ,u by the addition of dCTP,
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TABLE 1. Bacterial strains and plasmids
Bacterial strain or plasmid Descriptiona Reference
E. coli MH1 MC1061 derivative; araD139 lacX74 galU galK hsr hsm+ strA 4
L. lactis subsp. lactis IL1403 Plasmid-free 5
Plasmid
pMB225 Emr Bac+, 6.2 kb; containing 1.8-kb ScaI-ClaI fragment with low antagonistic activity 21
pMB553 Emr Bac+, 5.1 kb; containing 1.3-kb Scal-HindIII fragment with high antagonistic activity 21
pGKV210 Emr, 4.4 kb 24
pGKV410 Emr, 4.4 kb 24
pGKV259 Emr Cmr, 5 kb; pGKV210 derivative containing promoter P59 in multiple cloning site 24
a Bac+, Bacteriocin producer; Emr and Cmr, resistance to erythromycin and chloramphenicol, respectively.
dGTP, and dTTP to final concentrations of 100 ,uM each.
Then 1 ,ul of dATP from a 0.5 mM stock, 1 ,u1 of [a-35S]dATP
(1 ,uCi; 1,000 Ci/mmol), and 1 p.l of avian myeloblastosis
reverse transcriptase (30 U) were added. After 1 h of
incubation at 37°C, the reaction mixture was precipitated
with ethanol. The pellet was washed with 80% ethanol and
dissolved in 6 p.l of distilled water and 4 ,ul of sequencing
dye, and the sample was heated for 3 min in a boiling water
bath. To determine the start site of transcription, the exten-
sion reaction mixtures were run on an acrylamide sequenc-
ing gel. Sequence ladders primed with the same oligonucle-
otides were used as molecular weight markers..
Assay for bacteriocin activity in SDS-polyacrylamide gels.
To estimate the size of the bacteriocin molecule, 12.5 p.l of
the supernatant of a bacteriocin-producing late-exponential-
phase culture of L. lactis was applied to a sodium dodecyl
sulfate (SDS)-polyacrylamide (15%) gel (12) next to a molec-
ular weight standard (Rainbow protein molecular weight
marker; Amersham International, Amersham, England).
The sample was mixed in a 1:1 ratio with 2 x loading buffer
for polyacrylamide gel electrophoresis (PAGE) (18) and was
heated to 100°C for 10 min. After electrophoresis, the gel
was washed as described by Bhunia et al. (1) and put on a
glucose-M17 (20) agar plate. An indicator lawn of 4 ml of soft
glucose-M17 agar (0.7%), containing 100 p.l of an overnight
culture of L. lactis IL1403, was poured on the surface. After
15 h of incubation at 30°C, the plate was examined for zones
of inhibition of growth.
RESULTS
Nucleotide sequence of the bacteriocin genes on pMB225
and pMB553. The nucleotide sequence of the 1.8-kb DNA
fragment specifying low antagonistic activity is shown in
Fig. 1. Three ORFs, each preceded by a putative ribosome
binding site, were identified within this sequence. The first
ORF (ORF-A1) could encode a polypeptide of 69 amino
acids and is followed by an ORF (ORF-A2) able to encode a
polypeptide of 77 amino acids. ORF-A2 is followed by a
third ORF (ORF-A3) with 154 codons. The nucleotide se-
quence of the region downstream of ORF-A3 revealed
neither additional ORFs nor palindromic sequences which
might function as rho-independent transcriptional termina-
tion sites. Directly upstream of ORF-A1 two putative pro-
moters were found, designated promoter P1 and promoter
P2. The -35 sequence of promoter P1 corresponded more
closely to the consensus -35 sequence of lactococcal pro-
moters than promoter P2 (24). Also, the spacing of 16 bp
between the -35 region and the -10 region of promoter P1
agreed more closely to the usual spacing in L. lactis promo-
tors than to that in the promoter sequence P2.
Figure 2 shows the first 1,048 nucleotides of the 1.3-kb
Scal-HindIlI fragment specifying high bacteriocin activity.
Two ORFs (ORF-B1 and ORF-B2) were present which could
encode polypeptides of 75 and 98 amino acids, respectively.
Both ORFs were preceded by a putative ribosome binding
site. In the nucleotide sequence two inverted repeats were
identified which could act as rho-independent terminators,
one 11 bp and one 104 bp downstream of the TAA stop
codon of ORF-B2. The putative stem-and-loop structures
had AG's of -130 and -96 kJ/mol, respectively. The first 378
nucleotides of the 1.8- and 1.3-kb fragments (starting at ScaI
site present at the 5' end of the fragment) were identical.
This implies that the regulatory region preceding ORF-A1
and ORF-B1 as well as the first 20 bp of ORF-A1 and
ORF-B1 were identical. Downstream of these identical re-
gions the sequences on the two fragments presented in Fig.
1 and 2 did not reveal further nucleotide sequence similarity.
The deduced amino acid sequences of the different ORFs
were compared for sequence similarities. Only between
ORF-A1 and ORF-B1 was significant similarity found (Fig.
3).
Determination of the transcription start sites. The start sites
of transcription were determined by primer extension.
RNAs from L. lactis IL1403(pMB225) and IL1403(pMB553)
were hybridized with oligonucleotides specific for ORF-A1
(5'-CCACCAACAGCACCGCC-3') and ORF-B1 (5'-CATC
CATTAACAATGGT-3'), respectively. Comparison of the
DNA bands synthesized from these primers with DNA
sequencing ladders as standards showed that transcription
started 12 bp downstream of the proposed (-10) TATAAT
box of promoter P1 on the 1.8-kb fragment and 14 bp
downstream of this box on the 1.3-kb fragment (Fig. 4).
Mutation analyses. The sequence data of the cloned inserts
of pMB225 and pMB553 were analyzed for restriction sites,
using MicroGenie software (Beckman, Palo Alto, Calif.).
Several restriction sites were found which could be used for
in vitro deletion, for the introduction of frameshift muta-
tions, and for subcloning fragments in the pWVO1-derived
(11) shuttle vector pGKV210, pGKV410, or pGKV259 in E.
coli. The mutated derivatives were transferred to L. lactis
IL1403 and screened for bacteriocin activity and immunity.
The results of these experiments with pMB225 carrying
the 1.8-kb ScaI-ClaI fragment specifying low bacteriocin
activity are presented in Fig. 5. Plasmid pMB229, containing
a frameshift mutation in ORF-A1, was constructed by filling
in the AsuII site with Klenow DNA polymerase, resulting in
an NruI site. This mutation caused loss of antagonistic
activity, but not of immunity, implying that ORF-A1 is
involved in bacteriocin production. Deleting the AluI-ClaI
fragment downstream of ORF-A1 resulted in plasmid
pMB242. L. lactis cells containing this plasmid showed a
Bac- Imm- phenotype, indicating that sequences in addition
to ORF-A1 were involved in bacteriocin production. To
VOL. 57, 1991
494 VAN BELKUM ET AL.
SW ~ ~ UATACTCAAATTTCGGAATGAAAGT GTCAAAAAGMAGATTTACAGTACAGCAAAATTTACCTCAACCT)AAATTTTAACTccAATA 90
ATCAACCAAATAGATAG7GCTCCCACAGC TTAAAGAGGGAAATGCTTATAAAGTTTCTGCGACAACCACTATCAATGCAAAAGACCTC 180
CCAAATATCCGATA51GTCTTCAGGGAAAACGTAACCATTATAGGAAAGAAMCTTATTTCAATTACTTTTTMATAAAATAATGGGA
P1 -35 P1 -10 * rbs start
AGAGGCAATCAGTAGAGTTATTAACATT SST"AGTTTTAT?TTATATAATCTATAATAGATTTATAAATAAGGAGATTATTAT
P2 -35 P2 -10 N
ORF-A1 &zurZGAAAAATCAATTAAATTCGAAATCCTATCAGAXGA2GAGTTACAAGGTATCAATGGCGGTATCAdAGGTACTGGTAMGGGCTTAGCTXC
K N Q L N E I L S D 9 E L Q G I N G I R G T G K G L A A
a r,!rr T &WI AU&J
CGCAAGGTCGGGGGCCGCAMGG7GGAGCTATAGGAGCTTTGGGGTCCAGTAGGXCTATTATGGGCGL GG,
A M V S G A A N G G A I G A P G G P V G A I M G A WG
stop ORF-Al rbs start ORF-A21q1TGTGCCAAGAAATATTCTATATAAAAATTGAAAGGATTCAGGTACTAAAATGAAAAAAGA1GAAGCAAATACATTTAAAGAATATTOdGA M X Y S I M K K D E A N T EX S Y
US
CCTCATCCTTCGCTATTTTACGGATGAAGAACTAGAAMATATTAA7GGATCTGGATCAATCTGGGGGAGCGATITC7GGAGGAGCTGTAA
S S S F A I V T D E E L E N I N G S G S I W G A I A G G A V
AAGGGGCAATCGC1'GCCTCTTGGACTGGTAATCCTGTCGGTATAGGATGTCAGCATTAGGAGGCGCCGTTTTGGGTGGAGTAACTTATG
X G A I A A S W T G N P V G I G M 8 A L G G A V L G G V T Y
stop ORF-A2 rbs start ORF-A3 bL
CTAGACCAGTACACTAAAGAAAGGCTTACAAATTAATGAAAAAMGATAATTTTTTAATAAATAGATTCTTGGAATACCTTCAAAACTA
A R P V H H K N D N F L I N R F L G I P S K A
TTTTAAGTAAGAAGGTTCTATAAAAATAGGAAAAACATTAAGTATTTATGGAGTGTTSCATT7T-ATTTAATATTATTATCT CTT
I L S E E G S I K I G KT L S I Y G V V S P L F N II I F A
TTATATCTCTATTATTAATAAATAATAATAACGCTTYATATAT$G TSTTG G;GT7TTTATSGCCAATATGGTATTACCTCTACCSTTw-
F I S L LL I N N N N A L Y I V L F G F I A N M V L P L P F
TATACTATATAAAACGACATAATTATGA7GAAATCACAAATAAATTWAAATAAAAAATAAAATCCCTTGGGGACAGGCATTATTATAA
L Y Y I I R H N Y D E I T N R P E I 1 N 1 I P W G T G I I I
TIVYYVL VFFMPNINNAPDGNTALISICAA MTATATTACG TTTTATCCGTTTTTTCAGCCAA TATAC TiCTCmACGGGAA ACTGCTCTAATATCAAiTGGCT













NIATTU stop ORF-A3 so!
T1GG5ATATTCA0GACAGTAGTA-0TTACTTTATAAAGTAATAGTAGGAAGA CCTATTGGCACTGTAA GTATA 13S0




TA1TAAGATTGGTTCT2TTGTTAGT TT0TAATCACTATGCAAAT7GAGTT TACTCTAGCCACTGTT TCATCC1620
TACTTATGATTATTTATTTTATTCTTTAGACTATTTTTAAATGATGATAAAGAAAGTAATCACTTATAGAATTAATCATTACTTACC 1710
ATTMMCCCAGTCGAGTTAlGTGACTGGCm TAAATCATTCTATCAMAAT AATCAT
FIG. 1. Nucleotide and deduced amino acid sequences of the 1.8-kb ScaI-ClaI fragment. The deduced amino acid sequences of the three
ORFs are shown below the nucleotide sequence. The -35 and -10 regions of the possible promoters P1 and P2 are indicated. Putative
ribosome binding sites (rbs) are underlined. The asterisk above the sequence indicates the start site of transcription determined by primer
extension. Restriction sites for mutagenesis are indicated. The dotted line represents the sequence used for the primer extension assay.
identify these sequences also, a frameshift mutation was
made in ORF-A2 by filling in the unique Narl site, changing
it into a BssHII site. Cells carrying the resulting plasmid
pMB246 were Bac- Imm+. Cells that carried plasmid
pMB248, containing an AsuII-NarI deletion encompassing
both ORF-A1 and ORF-A2, were also Bac- Imm+. From
these data we conclude that both ORF-A1 and ORF-A2 are
required for bacteriocin activity but not for immunity against
bacteriocin and that ORF-A3 was probably responsible for
immunity. Two lines of evidence support the supposition
that the three ORFs on pMB225 constitute a single operon,
as would be expected from the nucleotide sequence of the
1.8-kb ScaI-ClaI fragment. First, removal of the region
upstream of the AsuII site, which includes the promoter and
the 5' part of ORF-A1, resulted in a Bac- Imm- phenotype
(pMB226). Apparently, transcription of ORF-A3 is depen-
dent on the promoter upstream of ORF-A1. Second, when
the 1.4-kb HaeIII-ClaI fragment of pMB226 was cloned
behind the lactococcal promoter P59 of pGKV259 (24),
yielding pMB241, the immunity-positive phenotype was
APPL. ENVIRON. MICROBIOL.




P1 -35 P1 -10 * rbs start
AGAGGCAATCAGTAG;AGTTATTACATTuwrIGT kMAG T$TTi$sTsA ATTTATAAAATAA GS;ATTATTAT
P2 -35 P2 -10 n
ORF-Bl-
GAAAAATCAATTAAATTTTAATAT CTCAAACTAACGGGAA AT TCAATA$ACAGGC
K N Q L N F N I V S D E E L S E A N G G K L T P I Q S T A A
SGGAGATTTATATTACLANACTNTKACACACYAVATQGTQTACCAACAANCTCAAFC GAGCAGC$GCTAATACCATVTTN





G d N G G A A G G P G L H H n x K K Q I E F E N
GAG;CTAAG;AAGTATGTTGGCTACCCCCCT7GAAAGACATxTtAGT;AGAGA ATGCTC TGAATATTGCA AGAAAAGGCGCTAC
E L R S M L A T A L E K D I S Q E E R N A L N I A E K A L D
AATTCTGAATATTTACCAAAAATTATrAAACCTCAGAAAACCCTAACTCCATTAGCTATAAATcGAACACT?AACCATGAITTATT
N S E Y L P K I I L N L R K A L T P L A I N R T L N H D L S
stop ORF-B2
GAACTGTATAAATTCATTACAAGTTCCAAAGCATCAAACAAAAATTTG1GTGGmAGTTATTTTCGTCGGGACGACTATTCTAATAA









FIG. 2. Nucleotide and deduced amino acid sequences of the first 1,048 nucleotides of the 1.3-kb ScaI-HindIII fragment. The deduced
amino acid sequences of the two ORFs are shown below the nucleotide sequence. The putative -35 and -10 regions of promoters P1 and
P2 as well as the putative ribosome binding sites of the two ORFs are indicated. The start site of transcription as determined by primer
extension is marked with an asterisk. Restriction sites for mutagenesis are indicated. The inverted repeats downstream of the second ORF
are underlined by solid arrows. The region upstream of the vertical open arrow represents the region of identity between the 1.3-kb fragment
and the first 378 nucleotides of the 1.8-kb ScaI-ClaI fragment. The dotted line represents the sequence used for the primer extension assay.
restored. As expected from the sequence data, deletion of
the SnoI-ClaI fragment of pMB225 (pMB249) did not inter-
fere with immunity.
To investigate the effect on transformation of L. lactis
with a plasmid carrying undisturbed ORFs Al and A2, but
carrying a 3' deletion in ORF-A3, pMB250 was constructed
in E. coli. In pMB250 ORF-A3, the presumed immunity gene
had been partly deleted by removal of a 0.14-kb NlaIII
fragment. Upon introduction of pMB250 in L. lactis, trans-
formants were detected and appeared to produce bacterio-
cin, but the colonies were small, indicating impeded growth
of cells producing a nonfunctional ORF-A3 product. No
transformants developed on plates in which the growth
medium had been supplemented with a 50% (vol/vol) super-
ORF-Al XKNQ L NF E I L S D E E L Q G I N G G I
ORF-B1 M K N Q L N F N I V S D E E L S E A N G G K L T F I
ORF-A1 R G T G K G L A A A M V S G A A M G G A I G A F
ORF-B1 Q S T A A G D L Y Y N T N T H K Y V Y Q Q T Q N A F
ORF-A1 G G P V G A I M G A W G G A V G G A M K Y S I
ORF-B1 G A A A N T I V N G W M G G A A G G F G L H H
FIG. 3. Homology comparison of the deduced amino acid se-
quences of ORF-A1 and ORF-B1. Colons indicate amino acid
identity; periods indicate conservative substitution.
natant culture of the bacteriocin-producing strain IL1403
(pMB225). Apparently, the initial concentration of bacterio-
cin produced by the transformants in the plates was insuffi-
cient to completely suppress the growth of the transformed
cells. These results strongly suggest that ORF-A3 specified
immunity.
Figure 6 shows the different mutation derivatives of
pMB553. Deleting the 0.1-kb CfoI fragment, encompassing
the 3' part of ORF-B1 and the 5' part of ORF-B2 (pMB560),
resulted in loss of both bacteriocin production and immu-
nity. L. lactis transformants containing a plasmid in which
the promoter region and the 5' part of ORF-B1 were re-
moved by deleting the 0.54-kb ScaI-FokI fragment of
pMB553 (pMB562) were Bac- Imm-. Immunity but not
bacteriocin production could be restored when promoter 59
was cloned upstream of the remaining part of the bacteriocin
operon of pMB562 (yielding plasmid pMB563). These results
indicate that ORF-B1 is involved in bacteriocin production
and ORF-B2 specifies immunity and that these ORFs are
transcribed as an operon. Further support for ORF-B2 being
the immunity gene was provided by the observation that
transformantion of L. lactis with plasmid pMB561, carrying
a deletion in ORF-B2, gave rise to only very small colonies
of transformants producing bacteriocin. When the plates
were supplemented with a 30% (vol/vol) supernatant culture
of the bacteriocin-producing strain IL1403(pMB553), no
transformants of L. lactis were obtained with pMB561.
Apparently also in this case, the initial concentration of the
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FIG. 4. Determination by primer extension of start site of trans-
cription of the two bacteriocin operons. (A) Lane 1 shows the primer
extension product ofRNA from IL1403(pMB225). (B) Lane 1 shows
the primer extension product of RNA from IL1403(pMB553). The
sequence ladders in panels A and B were produced by using the
same primers and are shown for each reaction (GATC).
bacteriocin produced by the L. lactis transformants was too
low to completely inhibit the growth of the transformants.
SDS-PAGE. To examine whether the size of the bacterio-
cin molecule specified by pMB553 is in agreement with the
expected molecular weight of the polypeptide that could be
encoded by ORF-B1 (approximately 8,100), a sample of the
supernatant of a culture of IL1403(pMB553) was subjected
to SDS-PAGE and subsequently examined for bacteriocin
activity. A zone of inhibition of growth could be detected at
a position around 3.4 kDa (Fig. 7). This indicates that the
bacteriocin molecule specified by pMB553 has an aberrant
mobility on SDS-PAGE and/or is subject to processing. A
sample of the supernatant of IL1403 did not show antago-
nistic activity in an SDS-polyacrylamide gel (Fig. 7). When
L. lactis indicator cells were used which contained pMB553,
no zones of inhibition of growth were detected (results not
shown). The same procedure was used to test the pMB225-
specified bacteriocin. Probably because of its lower antago-
nistic activity, no zone of inhibition of growth was observed
with IL1403 as the indicator strain (results not shown).
+ + pMB249
' + - pMB250
FIG. 5. Phenotype of various mutation derivatives of pMB225.
The restriction enzyme map and the location of ORF-A1, -A2, and
-A3 on the 1.8-kb ScaI-ClaI fragment of pMB225 are shown. Of the
six AluI sites, only one is presented. The lines represent the parts of
the 1.8-kb fragment present in the various subclones. Asterisks
indicate frameshift mutations of the ORFs (for details, see text). The
thick bar represents promoter P59. The arrow indicates direction of
transcription. Bacteriocin production (Bac) and immunity (Imm)
expressed by the various plasmids are indicated.
sible for immunity. Sequence and mutation analyses of the
1.3-kb ScaI-HindIII fragment specifying the higher activity
present on pMB553 showed that one ORF was responsible
for bacteriocin activity (ORF-B1) and another was respon-
sible for immunity (ORF-B2). Transformation of an L. lactis
strain which originally did not show antagonistic activity,
using plasmid pMB553, resulted in the production by the
transformant of a bacteriocin with a specificity identical to
that of the strain from which the plasmid-borne DNA frag-
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We present the results of the nucleotide sequence analysis
of two DNA regions which specify bacteriocin production as
well as immunity from the lactococcal plasmid p9B4-6.
Several ORFs on these fragments could be identified. The
sequence data of the 1.8-kb ScaI-ClaI fragment present on
pMB225, specifying low antagonistic activity, indicate the
presence of three ORFs (Fig. 1). Analysis of different
mutation derivatives of pMB225 indicated that the first two
ORFs (ORF-A1 and ORF-A2) were involved in bacteriocin




' + - pMB561
FIG. 6. Phenotype of various mutation derivatives of pMB553.
The restriction sites, as well as the locations of ORF-B1 and
ORF-B2 on the 1.3-kb Scal-HindIll fragment of pMB553, are
shown. The lines indicate the parts of the 1.3-kb fragment remaining
in the various subclones; the thick bar represents promoter P59. The
arrow indicates direction of transcription. Bac and Imm indicate the
phenotypes for bacteriocin production and immunity of the different
constructs, respectively.
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FIG. 7. Detection of bacteriocin activity in an SDS-polyacryl-
amide (15%) gel by overlayering the gel with glucose-M17 soft-agar
medium containing L. lactis IL1403. Lane 1, Molecular weight
standard; lane 2, supernatant of IL1403(pMB553); lane 3, superna-
tant of IL1403.
mutation analysis of the bacteriocin operon present on
pMB553 presented here, strongly suggests that ORF-B1 is
the structural bacteriocin gene of pMB553. If this idea is
correct, then we have to assume that the bacteriocin mole-
cule has an aberrant mobility in SDS-PAGE and/or is subject
to processing, as the size of the product that could be
specified by ORF-B1 is 8.1 kDa while the active bacteriocin
has a size of around 3.4 kDa. Considering the degree of
amino acid similarity of the products of ORF-A1 and
ORF-B1 (Fig. 3), it is conceivable that ORF-A1 encodes the
bacteriocin of pMB225. Why a second gene (ORF-A2) is
involved in pMB225-specified bacteriocin activity is unclear.
Conceivably, the polypeptide encoded by ORF-A2 is neces-
sary for the maturation and/or the secretion of the bacterio-
cin, or the bacteriocin encoded by pMB225, might be a
heterodimer of the ORF-A1 and ORF-A2 products.
The deduced amino acid sequence of ORF-B2 did not
show significant similarity to that of ORF-A3, which would
be expected on the basis of our previous observation that
ORF-A3-specified immunity does not give protection against
ORF-B1-specified bacteriocin, and vice versa.
The results of analysis of the nucleotide sequence and the
bacteriocin phenotype of the different mutation derivatives
suggest that on both fragments on pMB225 and pMB553 the
different ORFs are transcribed as an operon. The noncoding
region upstream of the ORFs, which contains two possible
promoters according to the sequence data, appeared to be
identical on both fragments. Thus, the difference in activity
we observed between IL1403(pMB225) and IL1403(pMB553)
(21) cannot be caused by a difference in promoter strength.
That the autoradiograms of the primer extension experi-
ments showed only one major band for both fragments
strongly suggests that only one of the two possible promot-
ers is used. The nucleotide sequence of promoter P1 con-
forms more to the L. lactis consensus promoter sequence
than that of promoter P2; thus, we think that promoter P1 is
the actual promoter used for transcription of the bacteriocin
operons. The sequence TAT is fairly common as the +1
region in which A is the initiating nucleotide. The primer
extension experiments indicate that the initiation of tran-
scription of the bacteriocin operon of pMB553 conforms to
this pattern, whereas transcription on the bacteriocin operon
of pMB225 started at a T 2 bp upstream of the central A.
Since the bacteriocin promoters are embedded in completely
identical regions on both fragments, we speculate that the
choice of different start sites of transcription is dictated by
the downstream region, which may cause a different nucle-
otide conformation at the transcription start site.
The complete identity of the regions upstream of the ORFs
of the two bacteriocin operons, including the first part of
their first ORF, is intriguing. Preliminary results indicate that
downstream of the bacteriocin operon on the 1.3-kb frag-
ment a sequence is present which is very similar to the
identical nucleotide sequences upstream of the two bacteri-
ocin operons. Whether this sequence is followed by a third
bacteriocin operon is presently under investigation. The
finding that the bacteriocin operon on the 1.3-kb fragment is
flanked by similar nucleotide sequences, which are similar to
the 5' flanking region of the bacteriocin operon on the 1.8-kb
fragment, suggests that these operons may be moved in the
lactococcus genome by transposition-like events.
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